Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA Adverse Event Reporting System database

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Safety
Published
2024-12-27
DOI
https://doi.org/10.1080/14740338.2024.2448205
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA Adverse Event Reporting System database

Cheng Jiang, Junxian Zheng, Shuangshuang Wu, Yiming Qi
1 citations
Expert Opinion on Drug Safety
Computational Drug Discovery Methods
0.36
article

Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA Adverse Event Reporting System database

Cheng Jiang, Junxian Zheng, Shuangshuang Wu, Yiming Qi
article en
1 citations

Abstract

No abstract available for this paper.
Expert Opinion on Drug SafetyVol. 24(4)
Zhejiang Chinese Medical University (CN), Tongde Hospital of Zhejiang Province (CN)
Natural Science Foundation of Zhejiang Province
Openalex Percentile: Top 32%
Computational Drug Discovery Methods
0.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.